Exidavnemab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Exidavnemab, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy [Phase 2]